Serum S100β protein in children with acute recurrent headache: A potentially useful marker for migraine

Headache

Volumn 45, Issue 10, 2005, Pages 1313-1316

  Papandreou, Ourania ^a   Soldatou, Alexandra ^a   Tsitsika, Artemis ^a   Kariyannis, Catherine ^b   Papandreou, Thalia ^a   Zachariadi, Asimina ^a   Papassotiriou, Ioannis ^b   Chrousos, George P ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

Biochemical marker of migraine; Childhood acute recurrent headache; Migraine; Serum S100 protein; Tension type headache

Indexed keywords

BIOLOGICAL MARKER; PROTEIN S100B; PROTEIN S 100;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; HEADACHE; HUMAN; MIGRAINE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; STATISTICAL ANALYSIS; TENSION HEADACHE; ACUTE DISEASE; BLOOD; FEMALE; MALE; PROSPECTIVE STUDY;

ACUTE DISEASE; ADOLESCENT; BIOLOGICAL MARKERS; CHILD; FEMALE; HEADACHE; HUMANS; MALE; MIGRAINE DISORDERS; PROSPECTIVE STUDIES; RECURRENCE; S100 PROTEINS; TENSION-TYPE HEADACHE;

EID: 33645729313     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2005.00263.x     Document Type: Article

References (23)

1. Bille B. Migraine in school children. Acta Paediatr. 1962;51:16-151.
2. Abu-Arefeh I, Russel G. Prevalence of headache and migraine in schoolchildren. BMJ. 1994;309:765-769.
3. Headache Classification Committee of the International Headache Society. Classification and diagnosis criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1998;8(suppl 7):1-96.
4. de Grauw TJ, Hershey HD, Powers SW, Benti AL. Diagnosis of migraine in children attending a pediatric headache clinic. Headache. 1999;39:481-485.
5. Winner P, Martinez W, Mate L, Bello L. Classification of pediatric migraine: Proposed revisions to the IHS criteria. Headache. 1995;35:407-410.
6. Winner P, Wasiewski W, Cladstein J, Linder S. Pediatric Headache Committee of American Association for the Study of Headache: Multicenter prospective evaluation of proposed pediatric migraine revision to the IHS criteria. Headache. 1997;36:545-548.
7. Seshia SS, Wolstein JR, Adams C, Booth FA, Reggin ID. International headache society criteria and childhood headache. Dev Med Child Neurol. 1994;36:419-428.
8. Zimmer DB, Cornwall EH, Lander A, Song W. The S100 protein family: History, function and expression. Brain Res Bull. 1995;37:417-429.
9. Donato R. S100: A multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol. 2001;33:637-668.
10. Van Eldik LJ, Wainwright MS. The Janus face of glial derived S100β: Beneficial and detrimental function in the brain. Restor Neurol Neurosci. 2003;21:97-108.
11. Rothermundt M, Peters M, Prehn JH, Arolt V. S100β in brain damage and neurodegeneration. Microsc Res Tech. 2003;60:614-632.
12. Ikeda Y, Hayashi M, Dohi K, Matsumoto K. Biochemical markers for brain damage. Neurosurg Q. 2001;11:173-180.
13. Ingebringten T, Romer B, Kongstad P, Langbakk B. Increased serum concentration of protein S100β after minor head injury: A biochemical serum marker with prognostic value. J Neurol Neurosurg Psychiatry. 1995;59:103-104 [Letter].
14. Jackson RG, Samra GS, Radcliffe S, Clark GH, Price CP. The early fall in levels of S100 beta in traumatic brain injury. Clin Chem Lab Med. 2000;38:1165-1167.
15. Wiesmann M, Missler U, Gottmans D, Gehring S. Plasma S100β protein concentration in healthy adults is age and sex independent. Clin Chem. 1998;44:1056-1058.
16. Portella L, Tort AB, Schaf D, et al. The serum S100β concentration is age dependent. Clin Chem. 2000;48:950-952.
17. Wainwright MS, Craft JM, Griffin WST, et al. Increased susceptibility of S100β transgenic mice to perinatal hypoxia-ischemia. Ann Neurol. 2004;56:61-67.
18. Hu J, Ferreira A, Van Eldik LJ. S100β induces neuronal cell death through nitric oxide release from astrocytes. J Neurochem. 1997;69:2294-2301.
19. Koppal T, Lam AGM, Guo L, Van Eldik LJ. S100β proteins that lack one or both cysteine residues can induce inflammatory responses in astrocytes and microglia. Neurochem Int. 2001;39:401-407.
20. Li Y, Barger SW, Lin L, Mrak RE, Griffin WS. S100β induction of the proinflammatory cytokine interleukin-6 in neurons. J Neurochem. 2000;74:143-150.
21. Olesen J, Thomsen LL, Lassern LH, Olesen IJ. The nitric oxide hypothesis of migraine and other vascular headaches. Cephalalgia. 1995;15:94-100.
22. Fulle S, Pietrangelo T, Mariggiò MA et al. Calcium and fos involvement in brain-derived Ca2+-binding protein (S100)-dependent apoptosis in rat phaeochromocytoma cells. Exp Physiol. 2000;85:243-253.
23. Huttunen HJ, Kuja-Panula J, Sorci G, Agneleth AL, Donato R, Rauvala H. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J Biol Chem. 2000;275:40091-40105.